A LC-MS/MS method to monitor the concentration of HYD-PEP06, a RGD-modified Endostar mimetic peptide in rat blood-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A LC-MS/MS method to monitor the concentration of HYD-PEP06, a RGD-modified Endostar mimetic peptide in rat blood

Published:2018-08 Issue: Volume:1092 Page:296-305
ISSN:1570-0232
Container-title:Journal of Chromatography B
language:en
Short-container-title:Journal of Chromatography B

Author:

Dong Xiaona,Zhang Yiwei,Meng Zhiyun,Zhu Xiaoxia,Gan Hui,Gu Ruolan,Wu Zhuona,Li Jian,Zheng Ying,Yang Baofeng,Dou Guifang

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry

Reference32 articles.

1. Antiangiogenesis in cancer therapy—endostatin and its mechanisms of action;Folkman;Exp. Cell Res.,2006

2. Endostatin derivative angiogenesis inhibitors;Zheng;Chin. Med. J.,2009

3. Phase II study of cisplatin/etoposide and endostar for extensive-stage small-cell lung cancer;Zhou;Cancer Chemother. Pharmacol.,2011

4. Quantification of endostar in rat plasma by LC-MS/MS and its application in a pharmacokinetic study;Li;J. Pharm. Biomed. Anal.,2012

5. Therapeutic efficacy of recombinant human endostatin combined with chemotherapeutics in mice-transplanted tumors;Zhu;Eur. J. Pharmacol.,2009

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptidomics;Nature Reviews Methods Primers;2023-03-30

2. Evaluation of the metabolism of PEP06, an endostatin-RGDRGD 30-amino-acid polypeptide and a promising novel drug for targeting tumor cells;J PHARM ANAL;2022

3. Evaluation of the metabolism of PEP06, an endostatin-RGDRGD 30-amino-acid polypeptide and a promising novel drug for targeting tumor cells;Journal of Pharmaceutical Analysis;2022-10

4. Recent advances in mass spectrometry analysis of neuropeptides;Mass Spectrometry Reviews;2021-09-24

5. HYD-PEP06 suppresses hepatocellular carcinoma metastasis, epithelial–mesenchymal transition and cancer stem cell-like properties by inhibiting PI3K/AKT and WNT/β-catenin signaling activation;Acta Pharmaceutica Sinica B;2021-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3